Health Canada just approved Zyprexa IM, the first INJECTABLE atypical antipsychotic
February 2004
Health Canada just approved Zyprexa IM, the first INJECTABLE atypical antipsychotic.
For years only older antipsychotics such as haloperidol came as injectables for acute psychosis.
But these older drugs cause lots of side effects... extrapyramidal symptoms, dystonia, sedation.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote